Research
The cost-effectiveness of Vancouver's supervised injection facility
Ahmed M. Bayoumi and Gregory S. Zaric
CMAJ November 18, 2008 179 (11) 1143-1151; DOI: https://doi.org/10.1503/cmaj.080808
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
The cost-effectiveness of Vancouver's supervised injection facility
Ahmed M. Bayoumi, Gregory S. Zaric
CMAJ Nov 2008, 179 (11) 1143-1151; DOI: 10.1503/cmaj.080808
Jump to section
Related Articles
Cited By...
- Opioid-related emergency department visits and deaths after a harm-reduction intervention: a retrospective observational cohort time series analysis
- Evaluating Montreals harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis
- Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review
- Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol
- Supervised injection sites: Prejudice should not trump evidence of benefit
- Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment
- Vancouver's supervised injection facility challenges Canada's drug laws
- Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics